| Ytd | 0.14% | |
| 1y | 20.38% |
| Open | 3.65 | Prev Close | 3.64 | Low | 3.37 | High | 3.67 | Mkt Cap | 382.72M |
| Vol | 873.62K | Avg Vol | 2.38M | EPS | -1.84 | P/E | -1.90 | Forward P/E | -3.35 |
| Beta | 0.47 | Short Ratio | 7.72 | Inst. Own | 106.93% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 3.32 | 200-d Avg | 3.56 | 1yr Est | 40.93 |
CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, co
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) on Monday shared a clinical safety update concerning the
[url="]Rocket Pharmaceuticals, Inc.[/url] (Rocket or the Company) (NASDAQ: RCKT), a fully integrated
CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (Rocket or the Company) (NASDAQ: RCKT)
Gainers American Shared Hospital (AMEX:AMS) stock rose 14.2% to $1.61 during Wednesday's after-
CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, co
Rocket Pharmaceuticals, Inc. (RCKT) Presents at Goldman Sachs 47th Annual Global Healthcare Conferen
Rocket Pharmaceuticals, Inc. (RCKT) Presents at Jefferies Global Healthcare Conference 2026 Transcri
CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, co
Rocket Pharmaceuticals shares fell after a wider-than-expected Q1 loss as the company focuses on the
CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, co
CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, co
Rocket Pharmaceuticals drops despite the FDA's accelerated approval of gene therapy Kresladi in seve
Foghorn Therapeutics (NASDAQ: FHTX - Get Free Report) and Rocket Pharmaceuticals (NASDAQ: RCKT - Get
Rocket Pharmaceuticals, Inc. (RCKT) Discusses FDA Approval of KRESLADI Gene Therapy for Severe Leuko
Rocket Pharmaceuticals (NASDAQ:RCKT) announced that the US Food and Drug Administration (FDA) has gr
Rocket Pharmaceuticals shares jumped 10% on Friday before the bell after the U.S. Food and Drug Admi
CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated bio
Rocket Pharmaceuticals (NASDAQ:RCKT) announced that the US Food and Drug Administration (FDA) has gr
Rocket Pharmaceuticals, Inc. (RCKT) Presents at TD Cowen 46th Annual Health Care Conference Transcri
Rocket Pharmaceuticals reports narrower-than-estimated Q4 loss. The company provides key updates on
William Blair notes FDA's tougher stance on gene therapy programs as AMT-130 faces uncertainty i
During Thursday, 849 stocks hit new 52-week lows.
Wednesday's session saw 784 companies set new 52-week lows.
During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week
On Friday, 431 companies hit new 52-week lows.
On Tuesday, 242 companies hit new 52-week lows.
On Monday, 671 companies achieved new lows for the year.
During Friday's session, 445 companies made new 52-week lows.
Stocks That Hit 52-Week Lows On Wednesday
Stocks That Hit 52-Week Highs On Friday
41 Biggest Movers From Yesterday
Stocks Which Set New 52-Week High Friday, September 14th
Stocks Which Set New 52-Week High Yesterday, September 13th
Stocks Which Set New 52-Week High Yesterday, September 11th
24 Stocks Moving In Tuesday's Pre-Market Session